Elonda

Prolactin inhibitor that acts by direct stimulation of the D2-dopamine receptors on pituitary lactotrophs, thus inhibiting prolactin secretion.

. Has a potent and long-lasting prolactin-lowering activity.

. Indicated for inhibition/suppression of physiological lactation & treatment of hyperprolactinaemic disorders.

. 84% of patients had normal serum prolactin levels after cabergoline treatment at doses 1 – 2 mg/ week.

. 90% showing the disappearance of Galactorrhea.

. 50 – 90% reduction in tumor size in female and male patients with micro- or macroprolactinoma.